Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2

FDA recall notice · announced January 5, 2022 · Gilead Sciences

Class I FDA/FSIS Class I: reasonable probability that use will cause serious adverse health consequences or death.

The product

Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2

Reason for recall

Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.

Notes

Distribution: Nationwide in the USA
Lot/code information: Lots: 2141001-1A, 2141002-1A, Exp. 01/2024
Quantity: 53,473 vials
Status: Terminated
Products in this recall event:
- Veklury (remdesivir) for injection, 100 mg/vial, Single-Dose Vial, Rx only, Manufactured for: Gilead Sciences, Inc., Foster City, CA 94404, NDC 61958-2901-2 (D-0299-2022)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.